RSA RCT: Attune RP TKA Versus LCS RP TKA

Joint Disease Clinical Trial

— ALKNEE  

Official title:

A CLINICAL RANDOMIZED CONTROLLED RSA TRIAL COMPARING THE CEMENTLESS ATTUNE ROTATING PLATFORM KNEE SYSTEM TO THE CEMENTLESS LCS ROTATING PLATFORM KNEE SYSTEM

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03101007
• Other study ID #: 2017.0027
• Status: Completed
• Phase: N/A
• Start date: July 25, 2017
• Est. completion date: June 5, 2021

Study information

• Verified date: April 2022
• Source: Spaarne Gasthuis
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The LCS Complete Cementless Knee by DePuy Synthes is a rotating platform knee replacement with a good clinical track record and good survival rates. The cementless ATTUNE Cruciate Sacrificing (CS) Rotating Platform Knee by DePuy Synthes has been designed to provide better range of motion and address the unstable feeling some patients experience during everyday activities, such as stair descent and bending. It is expected that the cementless ATTUNE Rotating Platform Knee will have regulatory approval early 2016. Patient inclusion will start after regular approval has been obtained. The objective of this study is to accurately assess and compare migration, clinical and radiological outcome and patient reported outcomes (PROMS) of two TKR prostheses: the Cementless ATTUNE Rotating Platform Cruciate Sacrificing Knee System and the LCS Complete Cementless Cruciate Sacrificing Knee System (rotating platform design), both by DePuy Synthes, Warsaw, Indiana, USA. In this single-blind, randomized non-inferiority trial, 32 patients with the ATTUNE Knee System and 32 patients with LCS Knee System will be included. The study population will consist of patients with symptomatic osteoarthritis of the knee scheduled for TKR surgery at the Department of Orthopaedics, Spaarne Gasthuis, Hoofddorp, The Netherlands. Annually 300 TKA procedures are performed in this department, of which about 95% is Osteo Arthritis (OA). The investigator anticipates that inclusion can be accomplished within a 1 year period and that the total study duration is 3 years. Main study parameters/endpoints are: - Migration, measured by means of RSA. - Patient Reported Outcome Measures by means of questionnaires.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 61
• Est. completion date: June 5, 2021
• Est. primary completion date: June 5, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 21 Years to 90 Years

Eligibility

Inclusion Criteria:

• Patient is diagnosed with osteoarthritis and requiring primary knee arthroplasty
• All consecutive patients ("usual care") are included to prevent selection bias in the migration analysis.
• Patient is capable of giving informed consent and expressing a willingness to comply with this study Exclusion Criteria: The patient has an a-priori risk for a posterior-stabilized total knee arthroplasty.
• Status after patellectomy
• In case flexion is less than 90 degrees
• The patient is unable or unwilling to sign the Informed Consent specific to this study
• The patient does not understand the Dutch or English language good enough to participate
• Patients indicated for revision arthroplasty
• Patient is diagnosed with rheumatoid arthritis
• When there are not enough markers visible in the baseline RSA photograph and it will not improve by placing the patient in another position, the patient will be excluded from the study (secondary exclusion criteria).

Related Conditions & MeSH terms

• Joint Disease
• Joint Diseases
• Musculoskeletal Disease
• Musculoskeletal Diseases
• Osteoarthritis
• Osteoarthritis Arthritis

Intervention

Device:
• ATTUNE Knee Prosthesis by DePuy
Total Knee Replacement (TKR) Surgery with cementless ATTUNE rotating platform Knee Prosthesis by DePuy
• LCS Knee Prosthesis by DePuy
Total Knee Replacement Surgery with cementless LCS rotating platform Knee Prosthesis by DePuy

Locations

Country	Name	City	State
Netherlands	Spaarne Gasthuis	Hoofddorp
Netherlands	Leiden University Medical Center	Leiden

Sponsors (2)

Lead Sponsor	Collaborator
Spaarne Gasthuis	Leiden University Medical Center

Country where clinical trial is conducted

Netherlands, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Migration, measured by means of RSA	Migration (MTPM in mm) of the prosthesis with respect to the host bone measured by means of roentgen stereophotogrammetric analysis (RSA).	2 Years
Secondary	EQ-5D	General Health: EuroQol 5 Dimensional (EQ-5D) Health Questionnaire measured using patient questionnaire	2 Years
Secondary	KOOS	Knee Function: Knee injury and Osteoarthritis Outcome Score (KOOS) measured using patient questionnaire	2 Years
Secondary	VAS pain	Pain score after activity and during rest; (Likert scale 0-10)	2 Years
Secondary	2 Anchor questions	Two anchor questions (Likert scale 1-7) about change in functioning and pain since surgery.	2 Years